Esperion Therapeutics (United States)

Esperion Therapeutics (United States)

Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Esperion Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

51%


Total
Publications

176


Total Open
Publications

90


Total
Citations

11K


Open Access
Percentage

51%


Total
Publications

176


Total Open
Publications

90


Total
Citations

11K

Wikipedia

Website

download

Breakdown

23% 24% 4% 49%

Publisher Open

23%

Both

24%

Other Platform Open

4%

Closed

49%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

02468101214161820Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

19%OA Journal

OA Journal 19%

16

Hybrid 65%

53

No Guarantees 16%

13

Other Platform Open

Domain 78%

39

Other Internet 22%

11

Institution 10%

5

Preprint 10%

5

Public 2%

1

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
39
Europe PMC
Domain
16
DOI
Other Internet
4
medRxiv
Preprint
3
Imperial College London - Spiral
Institution
3
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - TYPE ART
Other Internet
2
HAL
Other Internet
2
bioRxiv
Preprint
2
UWA - UWA Profiles and Research Repository
Other Internet
1
1 / 2

Data updated 7 April 2025

Share

Share

Share